Can You Die From Overdosing on Antidepressants?

Antidepressant overdoses can be fatal, but the risk varies enormously depending on which drug is involved. Older tricyclic antidepressants are responsible for a disproportionate share of overdose deaths, while newer SSRIs rarely kill when taken alone, even at many times the prescribed dose. The gap in lethality between the most and least dangerous antidepressants is so wide that choosing which drug to prescribe has become, in itself, a safety decision.

Not All Antidepressants Carry the Same Risk

If there is one fact that matters most here, it is this: antidepressant overdose danger depends almost entirely on which antidepressant was swallowed. Tricyclic antidepressants (TCAs) like amitriptyline and dosulepin have far higher fatality rates in overdose than selective serotonin reuptake inhibitors (SSRIs) like fluoxetine or sertraline. A large UK study found that TCAs had a case fatality rate roughly 28 times higher than SSRIs in overdose, with even the “safer” newer drugs like venlafaxine and mirtazapine sitting well above SSRIs in toxicity.¹ The differences are not small or academic. In the UK between 1987 and 1992, over 80% of all deaths from antidepressant overdose were caused by just two tricyclic drugs: amitriptyline and dosulepin.²

These differences exist not only between drug classes but also within them. Among the SSRIs, citalopram stands out as having a higher case fatality rate than the others.¹ A U.S. analysis of poison control center data spanning 15 years confirmed that while tricyclics and older monoamine oxidase inhibitors caused the highest morbidity and mortality, several newer drugs also appeared hazardous in overdose, including venlafaxine, bupropion, and citalopram.³

How Tricyclic Overdoses Kill

Tricyclics are the class most associated with fatal overdose, and the reason is primarily the heart. These drugs block sodium channels in cardiac tissue, which disrupts the electrical signals that keep the heartbeat coordinated. In overdose, this sodium channel blockade slows conduction through the heart’s wiring system, causing the electrical pattern on an ECG to widen and distort. That widening can progress to dangerous heart rhythms or outright cardiac arrest.⁴ Deaths from TCA overdose are usually caused by these abnormal rhythms or a dangerous drop in blood pressure, and they tend to happen within the first 24 hours after ingestion.⁵

The heart is not the only target. TCAs also affect the brain. Common signs of TCA poisoning include rapid heart rate, dilated pupils, dry mouth, and drowsiness. In severe cases, the person may develop seizures, fall into a coma, or stop breathing adequately.⁶ Seizures are an especially dangerous complication because they worsen the metabolic strain on the body and can accelerate cardiac instability. Among the tricyclics, dosulepin appears particularly likely to cause seizures, and amitriptyline is also considered one of the more toxic agents in the class.⁷

What makes TCA overdose so dangerous, compared with other antidepressants, is the narrow margin between a therapeutic dose and a lethal one. A person taking a standard daily prescription of amitriptyline at 150 mg might die after ingesting as little as a one- to two-week supply at once. That narrow margin has been a major reason clinicians have shifted toward prescribing newer, safer alternatives for patients at risk of self-harm.

SSRIs and the Relative Safety Gap

The development of SSRIs in the late 1980s and 1990s represented a genuine safety improvement in overdose scenarios. Over the first decade of SSRI availability, remarkably few fatal overdoses were reported involving an SSRI taken alone. Moderate overdoses of up to 30 times the normal daily dose were associated with minor or no symptoms. At higher amounts, the typical picture was drowsiness, tremor, nausea, and vomiting, uncomfortable but not life-threatening.⁸

“Safe” does not mean harmless, though. SSRIs can cause serotonin syndrome in overdose, a condition driven by excessive serotonin activity that produces muscle twitching, rapid heart rate, elevated body temperature, agitation, and in severe cases delirium or coma.⁹ A study of SSRI overdoses found that serotonin syndrome was actually common, but the outcomes were still relatively good compared to TCA poisoning.¹⁰

The important caveat is that SSRIs become much more dangerous when mixed with other substances. Many reported SSRI-related deaths involve co-ingestion of alcohol, benzodiazepines, or other medications. The combination of multiple serotonin-boosting drugs is the classic setup for severe serotonin syndrome, where the risk of death goes up significantly. An SSRI overdose in isolation is a medical emergency that usually resolves with supportive care, but that same overdose combined with another serotonergic drug is a far more precarious situation.

Drugs That Fall in the Middle

Several commonly prescribed antidepressants sit between the extremes of TCAs and SSRIs in terms of overdose danger, and a few of them deserve specific mention because patients and families often do not realize they carry elevated risk.

Venlafaxine, a serotonin-norepinephrine reuptake inhibitor (SNRI), has a higher case fatality rate than most SSRIs. That UK toxicity study placed its fatality rate about five times higher than the SSRI average.¹ In overdose, venlafaxine can cause seizures, and a review of California poison control data found that roughly 13% of reported venlafaxine ingestions involved seizure activity, with some seizures occurring up to 24 hours after swallowing the pills.¹¹ This delayed seizure risk complicates monitoring: a person who seems fine in the first few hours may still deteriorate.

Bupropion, often prescribed for depression and smoking cessation, is another drug that looks deceptively mild at prescribed doses but can turn dangerous in large amounts. Poison control data link bupropion to elevated morbidity and mortality indices in overdose.³ A case report of a teenager who ingested roughly 4.2 grams of extended-release bupropion illustrates the worst-case scenario: she experienced seizures, cardiac arrest, and required over 20 minutes of CPR. She survived but developed lasting neurological damage, including movement problems and cognitive deficits.¹² Extended-release formulations of bupropion are particularly tricky because the drug continues to be released over hours, creating a prolonged window of toxicity.

Mirtazapine, by contrast, is one of the safer options. A study of 89 single-agent mirtazapine overdoses found no seizures, no serotonin syndrome, no dangerous heart rhythm changes, and no deaths. The most common effects were elevated heart rate and blood pressure. Even patients who took very large doses (up to 1,350 mg) remained conscious, with the lowest level of alertness being only mildly depressed.¹³

What Happens in the Emergency Room

Hospital treatment for antidepressant overdose depends on which drug was taken and how severe the poisoning is. For TCA overdoses, the most important intervention is intravenous sodium bicarbonate. This has been the cornerstone of treatment for over half a century.¹⁴ Sodium bicarbonate works in two ways: it makes the blood more alkaline, which reduces the TCA’s grip on sodium channels, and it floods the body with extra sodium ions, which helps restore normal electrical conduction in the heart. In experimental models, sodium bicarbonate rapidly converted dangerous heart rhythms back to normal.¹⁵

Most TCA-poisoned patients respond to a standard dose or two of sodium bicarbonate. Occasionally, the heart rhythm abnormalities are stubborn. One published case required an extraordinary amount of sodium bicarbonate (2,650 milliequivalents, far beyond the usual dose) before the ECG finally normalized.¹⁶ Cases like that illustrate how resistant severe TCA poisoning can be.

When sodium bicarbonate is not enough, doctors have newer rescue options. Intravenous lipid emulsion therapy, originally developed for local anesthetic toxicity, has been used successfully in TCA cardiac arrests. One case involved a toddler who developed a life-threatening heart rhythm after TCA ingestion and recovered after lipid emulsion was added to standard treatment.¹⁷ Another described a 28-year-old woman in cardiac arrest from amitriptyline overdose whose blood pressure and pulse did not respond to high-dose sodium therapy but who stabilized after receiving lipid emulsion.¹⁸ The lipid emulsion essentially acts as a “sink” that soaks up the fat-soluble drug from the bloodstream, reducing its concentration at the heart.

For SSRI and SNRI overdoses, treatment is typically supportive. Patients are monitored for heart rhythm abnormalities, seizures, and serotonin syndrome. Benzodiazepines may be used for agitation or seizures. In cases of severe serotonin syndrome with dangerously high body temperature, aggressive cooling and sometimes the drug cyproheptadine (which blocks serotonin receptors) are used. The key with any antidepressant overdose is getting to a hospital quickly. Delays matter: the cardiac effects of TCAs, in particular, can progress from a slightly abnormal ECG to cardiac arrest in a short time.

Surviving an Overdose Does Not Always Mean Full Recovery

A common misunderstanding is that if someone survives an antidepressant overdose, they will return to normal once the drug clears. That is often true for mild overdoses, but severe cases can leave lasting damage. The bupropion case report mentioned earlier is a clear example: the teenager survived cardiac arrest but was left with Parkinson-like movement problems and cognitive difficulties.¹²

A case report of a 54-year-old man who took roughly 2,250 mg of amitriptyline in a suicide attempt traces the long arc of complications. On arrival he had altered consciousness, dangerously high body temperature, and metabolic acidosis requiring immediate mechanical ventilation and cooling. During his hospital stay he developed pneumonia that worsened into acute respiratory distress syndrome, requiring weeks of ventilator support and eventually a tracheostomy. He then developed profound weakness in his limbs from nerve damage related to his critical illness.¹⁹ Stories like his are a reminder that the period between “alive” and “well” can be long and painful.

Brain injury from lack of oxygen during cardiac arrest is the most feared long-term consequence. Even a few minutes of poor blood flow to the brain can result in memory problems, personality changes, or difficulty with coordination. Kidney damage from muscle breakdown (rhabdomyolysis, which occurs when prolonged seizures or immobility cause muscle tissue to release its contents into the blood) is another complication that can follow severe overdose of several antidepressant types.

Why the Same Dose Affects People Differently

Two people can take the same overdose amount of the same drug and have very different outcomes. Age, body size, and overall health play obvious roles, but genetics are an underappreciated factor. Most antidepressants are broken down by a family of liver enzymes called CYP450. People carry different genetic variants of these enzymes that make them faster or slower metabolizers. A “poor metabolizer” who breaks down the drug slowly ends up with higher blood levels from the same dose, which can make a survivable overdose lethal. A patient’s genetic profile can amplify exposure risk because many serotonergic drugs depend on these enzymes.²⁰

What else was taken matters at least as much as genetics. Alcohol slows drug metabolism and adds its own sedative effects. Benzodiazepines compound respiratory depression. Other serotonergic medications (including over-the-counter cough medicines containing dextromethorphan, the herbal supplement St. John’s wort, or the migraine drug class called triptans) can push serotonin levels higher and tip a moderate overdose into severe serotonin syndrome. The most dangerous overdose scenarios almost always involve multiple substances.

Formulation matters too. Extended-release pills keep releasing the drug for hours after ingestion, creating a delayed toxicity curve that can fool both the patient and the medical team. A person who feels only mild symptoms two hours after swallowing extended-release venlafaxine or bupropion may be in much worse shape four or six hours later. This is why emergency departments generally observe antidepressant overdose patients for extended periods, even when initial symptoms seem mild.

Interpreting Drug Levels After Death

Forensic investigators face an unusual challenge when trying to determine whether an antidepressant overdose caused someone’s death. After death, drugs redistribute from organs and tissues back into the blood, often pushing postmortem blood concentrations well above what the person actually experienced while alive. Standard clinical reference ranges for drug levels in living patients are of limited value in interpreting postmortem toxicology results.²¹ A postmortem blood level that looks like a massive overdose may actually reflect normal therapeutic use, because the drug concentrated in the blood after death. Forensic toxicologists account for this by sampling from specific body sites (typically the femoral vein in the leg, which is less affected by redistribution from the chest organs) and by considering the full clinical picture rather than relying on a single number.

This phenomenon occasionally matters for families. A coroner’s report listing a high drug level does not automatically mean the person took a deliberate overdose. Conversely, a seemingly modest level does not rule one out, because some of the drug may have already been metabolized before death. Toxicology interpretation in these cases requires expertise, and families should not hesitate to ask a medical examiner to explain how the conclusion was reached.

How Prescribing Practices Have Adapted

The wide differences in overdose lethality between antidepressant classes have reshaped how doctors prescribe. In many countries, guidelines now explicitly recommend avoiding tricyclics as a first-line treatment for depression, partly because of the overdose risk. This is especially true for patients who express suicidal thoughts, have a history of self-harm, or live alone without someone to notice signs of an overdose.

When a TCA is the best clinical option for a particular patient (tricyclics remain effective for certain pain conditions and treatment-resistant depression), some doctors prescribe smaller quantities at a time to limit the number of pills available for an impulsive overdose. Other strategies include using dispensing methods that make it harder to accumulate a dangerous supply. These measures are imperfect, since patients can stockpile pills, but they add a layer of friction that may prevent some impulsive acts.

The shift toward SSRIs and other newer antidepressants over the past three decades has likely contributed to a decline in antidepressant overdose deaths relative to total prescriptions, though the overall number of antidepressant prescriptions has risen so dramatically that overdose cases have not disappeared. The ongoing challenge is that some of the newer drugs people assume are safe in overdose, like bupropion and venlafaxine, carry more risk than a typical SSRI. Awareness of these differences matters, especially for patients who keep old prescriptions in medicine cabinets or for parents of teenagers who may have access to medications prescribed to other household members.